Clinical Outcomes in Patients With COVID-19 and Hematologic Disease

CONCLUSION: Patients with hematologic disease and COVID-19 have high mortality rates, predominantly due to COVID-19 complications. At a longer-term follow-up, no significant impact of COVID-19 on the course of a hematologic disease was revealed.PMID:37236904 | PMC:PMC10102503 | DOI:10.1016/j.clml.2023.04.002

Source: Clinical Lymphoma and Myeloma - May 26, 2023 Category: Cancer & Oncology Authors: Olga A Aleshina Kristina Zakurdaeva Anastasia N Vasileva Sergey K Dubov Vitaly S Dubov Vladimir I Vorobyev Lev S Butaev Alena M Sukhareva Lubov V Gavrilova Inessa Yu Toropova Marina O Popova Aleksandr A Siniaev Aleksandr D Kulagin Kamil D Kaplanov Andrei Source Type: research